| Application no. and date | 15744416.7 (espacenet) (Federated) (European Patent Register), 20150702 | | Patent/reg. no. and date | DK/EP 3317248, 20200916 | | Publication date | 20180509 | | Priority no. and date | | | EP pub. no. and date |
EP 3317248 20180509 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/162435 | | Inventor | WAYKOLE, Liladhar Murlidhar, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US,
HU, Bin, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US,
SUTTON, Paul Allen, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US,
HOOK, David, Novartis Pharma AG
Postfach
4002 Basel, CH,
KLEINBECK, Florian Karl, Novartis Pharma AG
Postfach
4002 Basel, CH,
MEIER, Ulrich, Novartis Pharma AG
Postfach
4002 Basel, CH,
MUELLER, Sibylle, Novartis Pharma AG
Postfach
4002 Basel, CH,
MUTZ, Jean-Paul, Novartis Pharma AG
Postfach
4002 Basel, CH,
SCHLOMACH, Jan, Novartis Pharma AG
Postfach
4002 Basel, CH,
WIETFELD, Bernhard, Novartis Pharma AG
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/221 (2006.01) , A61P 9/00 (2006.01) , C07C 229/34 (2006.01) | | Title | Sacubitrilcalciumsalte | | Int. application no. | US2015039010 | | Int. publication no. | WO2017003483 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
